Literature DB >> 15830353

Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse.

Alexandra A Blak1, Thorsten Naserke, Daniela M Vogt Weisenhorn, Nilima Prakash, Juha Partanen, Wolfgang Wurst.   

Abstract

Fibroblast growth factor 8 (FGF8) mediates the function of the midbrain-hindbrain organizer (MHO). FGF signals are transmitted by means of four known FGF receptors (FGFRs). Studies of Fgfr expression in early vertebrate development have shown that Fgfr1 is expressed along the entire neural tube, whereas Fgfr2 and Fgfr3 expression has been shown to spare the tissue adjacent to the MHO. The FGF8 signal from the MHO, therefore, was believed to be transmitted by FGFR1 exclusively. However, incongruent results from conditional mutants of Fgf8 and Fgfr1 in the midbrain-hindbrain (MHB) region contradict this hypothesis. Therefore, we reexamined the expression of the Fgfrs in this region. Fgfr1 is expressed all over the neural tube. Strikingly, Fgfr2 is expressed throughout the floor plate of the MHB region. In the basal plate, Fgfr2 directly abuts the Fgf8 expression domain at the MHO, anteriorly and posteriorly. Fgfr3 expression is in contact with the Fgf8 expression domain only in the rostroventral hindbrain. Based on these findings, we postulate a role for FGFR2 and FGFR3 in FGF signaling in the ventral midbrain and hindbrain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830353     DOI: 10.1002/dvdy.20386

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  20 in total

1.  Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome.

Authors:  Greg Holmes; Claudio Basilico
Journal:  Dev Biol       Date:  2012-06-01       Impact factor: 3.582

2.  Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.

Authors:  Anne M Moon; Deborah L Guris; Ji-heui Seo; Leiming Li; Jennetta Hammond; Amy Talbot; Akira Imamoto
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

Review 3.  Genetic networks controlling the development of midbrain dopaminergic neurons.

Authors:  Nilima Prakash; Wolfgang Wurst
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

Review 4.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

Review 5.  Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism.

Authors:  Flora M Vaccarino; Elena L Grigorenko; Karen Müller Smith; Hanna E Stevens
Journal:  J Autism Dev Disord       Date:  2008-10-13

6.  Unrelated developmental neurotoxicants elicit similar transcriptional profiles for effects on neurotrophic factors and their receptors in an in vitro model.

Authors:  Theodore A Slotkin; Frederic J Seidler; Fabio Fumagalli
Journal:  Neurotoxicol Teratol       Date:  2008-12-13       Impact factor: 3.763

7.  Fibroblast growth factor deficiencies impact anxiety-like behavior and the serotonergic system.

Authors:  Leah R Brooks; Courtney L Enix; Samuel C Rich; Jinno A Magno; Christopher A Lowry; Pei-San Tsai
Journal:  Behav Brain Res       Date:  2014-02-07       Impact factor: 3.332

8.  Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro.

Authors:  Theodore A Slotkin; Frederic J Seidler; Fabio Fumagalli
Journal:  Brain Res Bull       Date:  2008-02-01       Impact factor: 4.077

9.  Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain.

Authors:  Jonna Saarimäki-Vire; Paula Peltopuro; Laura Lahti; Thorsten Naserke; Alexandra A Blak; Daniela M Vogt Weisenhorn; Kai Yu; David M Ornitz; Wolfgang Wurst; Juha Partanen
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

10.  Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes.

Authors:  Cheryl C Tan; Martin J Walsh; Bruce D Gelb
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.